Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
EZETIMIBE
SANIS HEALTH INC
C10AX09
EZETIMIBE
10MG
TABLET
EZETIMIBE 10MG
ORAL
15G/50G
Prescription
CHOLESTEROL ABSORPTION INHIBITORS
Active ingredient group (AIG) number: 0149164001; AHFS:
APPROVED
2015-01-07
1 PRODUCT MONOGRAPH PR EZETIMIBE EZETIMIBE TABLETS 10 MG MANUFACTURER’S STANDARD Cholesterol Absorption Inhibitor Sanis Health Inc. Date of Revision: 1 President’s Choice Circle January 11, 2022 Brampton, Ontario L6Y 5S5 Submission Control No.: 259721 2 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION .............................................................3 SUMMARY PRODUCT INFORMATION .................................................................................. 3 INDICATIONS AND CLINICAL USE ........................................................................................ 3 CONTRAINDICATIONS ............................................................................................................. 4 WARNINGS AND PRECAUTIONS ............................................................................................ 4 ADVERSE REACTIONS .............................................................................................................. 7 DRUG INTERACTIONS ............................................................................................................ 10 DOSAGE AND ADMINISTRATION ........................................................................................ 12 OVERDOSAGE .......................................................................................................................... 13 ACTION AND CLINICAL PHARMACOLOGY ...................................................................... 13 STORAGE AND STABILITY .................................................................................................... 15 DOSAGE FORMS, COMPOSITION AND PACKAGING ....................................................... 15 PART II: SCIENTIFIC INFORMATION ...................................................................................16 PHARMACEUTICAL INFORMATION .................................................................................... 16 CLINICAL TRIALS ......................................................................................... Կարդացեք ամբողջական փաստաթուղթը